These findings indicate that the H2AFZ possesses potential value as a novel prognostic indicator for HCC patients and is correlated with immune infiltration in HCC, laying a foundation for future study of HCC investigation and intervention. The gene discussed is H2AZ2; the disease is hepatocellular carcinoma.